Skip to main content
Hide
Call

Launching a new therapy or label expansion takes upfront strategy to change market behavior. You have to break the habits of past prescribers by educating them on a new alternative or expanded indication while simultaneously proactively hunting for the physicians who are actively diagnosing your target patient population right now.

Clinical lab data is the core engine that drives both.

By leveraging real-world lab data, commercial teams gain precise, timely insights into where the greatest opportunities lie—allowing you to drive rapid market adoption and deliver life-changing treatments to the patients who need them most.

How lab data maximizes your launch strategies

The depth and breadth of Quest real-world lab data

With Quest's extensive testing volume and national reach across diverse indications, our deidentified real-world lab data empowers biopharma commercial teams to find the right physicians and drive therapy adoption.

Get started: Customize your own commercial data

Identify your high-value physicians in a few easy steps.

The value of lab data in drug commercialization

Access resources to discover why leading pharma teams integrate Quest’s real-world commercial data to fuel their strategies.

How the precision of real-world lab data transforms rare disease patient identification 
Leveraging real-world lab data to reveal the hidden patient population 
Data-driven physician engagement for ultra-rare diseases
Case study: Commercializing rare disease treatment

Request a data proposal

Request a proposal to identify HCPs treating patients likely eligible for your therapy and enable physician alerts when patients meet predefined treatment criteria.

946

* indicates required